Kendall Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
7,180
-90
| -1% | -$25.9K | 0.55% | 52 |
|
|
2025
Q1 | $2.24M | Buy |
7,270
+475
| +7% | +$146K | 0.66% | 45 |
|
|
2024
Q4 | $2.4M | Buy |
6,795
+253
| +4% | +$89.3K | 0.7% | 44 |
|
|
2024
Q3 | $2.34M | Buy |
6,542
+340
| +5% | +$122K | 0.72% | 41 |
|
|
2024
Q2 | $1.98M | Buy |
6,202
+550
| +10% | +$175K | 0.66% | 45 |
|
|
2024
Q1 | $1.3M | Buy |
5,652
+1,440
| +34% | +$331K | 0.45% | 70 |
|
|
2023
Q4 | $926K | Buy |
4,212
+1,310
| +45% | +$288K | 0.36% | 91 |
|
|
2023
Q3 | $655K | Buy |
2,902
+1,557
| +116% | +$351K | 0.29% | 106 |
|
|
2023
Q2 | $297K | Buy |
+1,345
| New | +$297K | 0.13% | 160 |
|
|
2018
Q4 | – | Sell |
-1,690
| Closed | -$216K | – | 115 |
|
|
2018
Q3 | $216K | Sell |
1,690
-1,545
| -48% | -$197K | 0.18% | 104 |
|
|
2018
Q2 | $366K | Sell |
3,235
-1,275
| -28% | -$144K | 0.32% | 85 |
|
|
2018
Q1 | $507K | Buy |
4,510
+125
| +3% | +$14.1K | 0.44% | 70 |
|
|
2017
Q4 | $649K | Buy |
+4,385
| New | +$649K | 0.58% | 55 |
|